VALNEVA SE (AYJ.DE) Fundamental Analysis & Valuation

FRA:AYJ • FR0004056851

Current stock price

4.576 EUR
+0.08 (+1.69%)
Last:

This AYJ.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AYJ.DE Profitability Analysis

1.1 Basic Checks

  • AYJ had negative earnings in the past year.
  • AYJ had a negative operating cash flow in the past year.
  • In the past 5 years AYJ always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: AYJ reported negative operating cash flow in multiple years.
AYJ.DE Yearly Net Income VS EBIT VS OCF VS FCFAYJ.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • AYJ's Return On Assets of -26.86% is in line compared to the rest of the industry. AYJ outperforms 51.25% of its industry peers.
  • With a Return On Equity value of -80.02%, AYJ perfoms like the industry average, outperforming 51.25% of the companies in the same industry.
Industry RankSector Rank
ROA -26.86%
ROE -80.02%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
AYJ.DE Yearly ROA, ROE, ROICAYJ.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With a Gross Margin value of 46.53%, AYJ perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
  • AYJ's Gross Margin has declined in the last couple of years.
  • AYJ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
AYJ.DE Yearly Profit, Operating, Gross MarginsAYJ.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AYJ.DE Health Analysis

2.1 Basic Checks

  • AYJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AYJ has been increased compared to 1 year ago.
  • Compared to 5 years ago, AYJ has more shares outstanding
  • AYJ has a better debt/assets ratio than last year.
AYJ.DE Yearly Shares OutstandingAYJ.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AYJ.DE Yearly Total Debt VS Total AssetsAYJ.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • AYJ has an Altman-Z score of -0.66. This is a bad value and indicates that AYJ is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.66, AYJ is doing worse than 62.50% of the companies in the same industry.
  • AYJ has a Debt/Equity ratio of 0.89. This is a neutral value indicating AYJ is somewhat dependend on debt financing.
  • AYJ has a Debt to Equity ratio (0.89) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -0.66
ROIC/WACCN/A
WACC7.63%
AYJ.DE Yearly LT Debt VS Equity VS FCFAYJ.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

  • AYJ has a Current Ratio of 1.78. This is a normal value and indicates that AYJ is financially healthy and should not expect problems in meeting its short term obligations.
  • AYJ has a Current ratio (1.78) which is in line with its industry peers.
  • AYJ has a Quick Ratio of 1.36. This is a normal value and indicates that AYJ is financially healthy and should not expect problems in meeting its short term obligations.
  • AYJ has a Quick ratio of 1.36. This is in the lower half of the industry: AYJ underperforms 61.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.36
AYJ.DE Yearly Current Assets VS Current LiabilitesAYJ.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AYJ.DE Growth Analysis

3.1 Past

  • AYJ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1180.00%.
  • The Revenue has grown by 19.89% in the past year. This is quite good.
  • The Revenue has been growing slightly by 6.09% on average over the past years.
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.43%
Revenue 1Y (TTM)19.89%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%-35.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 31.23% on average over the next years. This is a very strong growth
  • AYJ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.36% yearly.
EPS Next Y-619.02%
EPS Next 2Y-113.75%
EPS Next 3Y105.69%
EPS Next 5Y31.23%
Revenue Next Year-7.65%
Revenue Next 2Y-1.79%
Revenue Next 3Y22.81%
Revenue Next 5Y14.36%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AYJ.DE Yearly Revenue VS EstimatesAYJ.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
AYJ.DE Yearly EPS VS EstimatesAYJ.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. AYJ.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AYJ. In the last year negative earnings were reported.
  • Also next year AYJ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AYJ.DE Price Earnings VS Forward Price EarningsAYJ.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AYJ.DE Per share dataAYJ.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AYJ's earnings are expected to grow with 105.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-113.75%
EPS Next 3Y105.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AYJ.DE Dividend Analysis

5.1 Amount

  • AYJ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AYJ.DE Fundamentals: All Metrics, Ratios and Statistics

VALNEVA SE

FRA:AYJ (3/13/2026, 7:00:00 PM)

4.576

+0.08 (+1.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-20
Earnings (Next)03-16
Inst Owners24.55%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap396.77M
Revenue(TTM)274.97M
Net Income(TTM)-120.41M
Analysts81.82
Price Target7.38 (61.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17%
Min EPS beat(2)-90.69%
Max EPS beat(2)56.68%
EPS beat(4)2
Avg EPS beat(4)-21.59%
Min EPS beat(4)-115.24%
Max EPS beat(4)62.87%
EPS beat(8)4
Avg EPS beat(8)-5.97%
EPS beat(12)6
Avg EPS beat(12)-29.73%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.23%
Min Revenue beat(2)-26.86%
Max Revenue beat(2)16.4%
Revenue beat(4)2
Avg Revenue beat(4)2.94%
Min Revenue beat(4)-26.86%
Max Revenue beat(4)26.97%
Revenue beat(8)3
Avg Revenue beat(8)-2.55%
Revenue beat(12)7
Avg Revenue beat(12)17.96%
Revenue beat(16)9
Avg Revenue beat(16)99.55%
PT rev (1m)1.89%
PT rev (3m)2.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.7%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.13%
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-2.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 2.64
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS3.17
BVpS1.74
TBVpS1.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.86%
ROE -80.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.53%
FCFM N/A
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.08%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.36
Altman-Z -0.66
F-Score4
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)101.58%
Cap/Depr(5y)231.17%
Cap/Sales(3y)9.04%
Cap/Sales(5y)14.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.43%
EPS Next Y-619.02%
EPS Next 2Y-113.75%
EPS Next 3Y105.69%
EPS Next 5Y31.23%
Revenue 1Y (TTM)19.89%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%-35.76%
Revenue Next Year-7.65%
Revenue Next 2Y-1.79%
Revenue Next 3Y22.81%
Revenue Next 5Y14.36%
EBIT growth 1Y-162.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-276.1%
EBIT Next 3Y56.77%
EBIT Next 5Y7.59%
FCF growth 1Y91.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.46%
OCF growth 3YN/A
OCF growth 5YN/A

VALNEVA SE / AYJ.DE Fundamental Analysis FAQ

What is the fundamental rating for AYJ stock?

ChartMill assigns a fundamental rating of 2 / 10 to AYJ.DE.


What is the valuation status of VALNEVA SE (AYJ.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to VALNEVA SE (AYJ.DE). This can be considered as Overvalued.


How profitable is VALNEVA SE (AYJ.DE) stock?

VALNEVA SE (AYJ.DE) has a profitability rating of 1 / 10.